Humasis (Korea) Performance
| 205470 Stock | KRW 1,833 57.00 3.02% |
On a scale of 0 to 100, Humasis holds a performance score of 2. The company retains a Market Volatility (i.e., Beta) of -1.06, which attests to a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Humasis are expected to decrease slowly. On the other hand, during market turmoil, Humasis is expected to outperform it slightly. Please check Humasis' jensen alpha, treynor ratio, and the relationship between the standard deviation and total risk alpha , to make a quick decision on whether Humasis' current trending patterns will revert.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Humasis Co are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Humasis sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Total Cashflows From Investing Activities | -31.4 B |
Humasis |
Humasis Relative Risk vs. Return Landscape
If you would invest 178,100 in Humasis Co on September 3, 2024 and sell it today you would earn a total of 5,200 from holding Humasis Co or generate 2.92% return on investment over 90 days. Humasis Co is generating 0.2088% of daily returns and assumes 6.004% volatility on return distribution over the 90 days horizon. Simply put, 53% of stocks are less volatile than Humasis, and 96% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Humasis Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Humasis' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Humasis Co, and traders can use it to determine the average amount a Humasis' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0348
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 205470 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.0 actual daily | 53 53% of assets are less volatile |
Expected Return
| 0.21 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Humasis is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Humasis by adding it to a well-diversified portfolio.
Humasis Fundamentals Growth
Humasis Stock prices reflect investors' perceptions of the future prospects and financial health of Humasis, and Humasis fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Humasis Stock performance.
| Return On Equity | 117.34 | |||
| Return On Asset | 0.41 | |||
| Profit Margin | 0.48 % | |||
| Operating Margin | 0.58 % | |||
| Current Valuation | 603.35 B | |||
| Shares Outstanding | 27.69 M | |||
| Price To Sales | 7.74 X | |||
| Revenue | 321.83 B | |||
| EBITDA | 38.07 B | |||
| Cash And Equivalents | 176.58 B | |||
| Cash Per Share | 962.18 X | |||
| Total Debt | 2.25 B | |||
| Debt To Equity | 0.18 % | |||
| Cash Flow From Operations | 205.02 B | |||
| Total Asset | 340.71 B | |||
About Humasis Performance
By analyzing Humasis' fundamental ratios, stakeholders can gain valuable insights into Humasis' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Humasis has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Humasis has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Ltd. develops, manufactures, and markets in-vitro diagnostics for the detection of cardiac marker, fertility hormone, infectious disease, tumor marker, and cotinine for home and laboratory use in South Korea and internationally. The company was founded in 2000 and is based in Anyang, South Korea. HUMASIS is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about Humasis performance evaluation
Checking the ongoing alerts about Humasis for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Humasis help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Humasis had very high historical volatility over the last 90 days |
- Analyzing Humasis' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Humasis' stock is overvalued or undervalued compared to its peers.
- Examining Humasis' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Humasis' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Humasis' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Humasis' stock. These opinions can provide insight into Humasis' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Humasis Stock analysis
When running Humasis' price analysis, check to measure Humasis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humasis is operating at the current time. Most of Humasis' value examination focuses on studying past and present price action to predict the probability of Humasis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humasis' price. Additionally, you may evaluate how the addition of Humasis to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |